when were glp 1 agonists approved for weight loss Indications GLP-1/GIP RA Summary Sheet and Beyond! Evolution of GLP‐1 Receptor Agonists

The results of the PIONEER-3 trial have now been published in the renowned journal Journal of the American Medical Association (JAMA) and are said to be trend-setting for future therapy of type 2 diabetes.

Evaluating what the research shows about GLP-1 medications and depression and suicidal ideation.

Here, we aimed to provide an overview of retatrutide's safety and effectiveness in treating obesity.

Experts suggest a quick "rebound" effect in appetite and metabolism after stopping the drug, compounded by the stress of pregnancy

Find the best new GLP-1 drug for you.

Some even suggest that GLP-1 agonists might have the potential to supplant MASH therapy in its entirety